BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26634029)

  • 1. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Smoking" guns: Questions. “Smoking” guns: Answers.
    Cooks T; Davis TK; Hu J; Metheny R; Schwartz M; Gerona R
    Pediatr Nephrol; 2016 Jan; 31(1):61-2, 63-6. PubMed ID: 25330878
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
    Tung CK; Chiang TP; Lam M
    East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spice/K2 drugs--more than innocent substitutes for marijuana.
    Zawilska JB; Wojcieszak J
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cannabinoid and marijuana exposures reported to poison centers.
    Forrester MB; Kleinschmidt K; Schwarz E; Young A
    Hum Exp Toxicol; 2012 Oct; 31(10):1006-11. PubMed ID: 22859662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
    Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
    Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report.
    Papanti D; Schifano F; Botteon G; Bertossi F; Mannix J; Vidoni D; Impagnatiello M; Pascolo-Fabrici E; Bonavigo T
    Hum Psychopharmacol; 2013 Jul; 28(4):379-89. PubMed ID: 23881886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Spice"--synthetic cannabinoids with dangerous effects].
    Personne M; Westerbergh J; Hammer-Pettersen L
    Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids.
    Loeffler G; Delaney E; Hann M
    Brain Res Bull; 2016 Sep; 126(Pt 1):8-28. PubMed ID: 27108542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis.
    Zarifi C; Vyas S
    Perm J; 2017; 21():. PubMed ID: 28488989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis and synthetic cannabinoids.
    Deng H; Verrico CD; Kosten TR; Nielsen DA
    Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial infarction associated with use of the synthetic cannabinoid K2.
    Mir A; Obafemi A; Young A; Kane C
    Pediatrics; 2011 Dec; 128(6):e1622-7. PubMed ID: 22065271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do police arrestees substitute legal highs for other drugs?
    Wilkins C; Parker K; Prasad J; Jawalkar S
    Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure.
    Argamany JR; Reveles KR; Duhon B
    Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of synthetic cannabinoid consumption by current cannabis users.
    Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
    Subst Abus; 2014; 35(2):184-9. PubMed ID: 24821356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.